{"id":138187,"date":"2023-11-14T18:10:03","date_gmt":"2023-11-14T23:10:03","guid":{"rendered":"https:\/\/cardiologynownews.org\/?p=138187"},"modified":"2023-11-14T18:10:03","modified_gmt":"2023-11-14T23:10:03","slug":"speech-novel-speech-analysis-technology-may-be-useful-for-early-recognition-of-worsening-heart-failure-events","status":"publish","type":"post","link":"https:\/\/cardiologynownews.org\/?p=138187","title":{"rendered":"SPEECH:  Novel speech analysis technology may be useful for early recognition of worsening heart failure events"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Key Points<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Novel speech processing technology has the potential to detect heart failure exacerbations before they happen, and may be better than the conventional weight monitoring approach.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Additional studies are needed to explore the generalizability, practicality, efficacy, and effectiveness of the HearO model.<\/span><\/li>\n<\/ul>\n<p><!--more--><\/p>\n<p><span style=\"font-weight: 400;\">Speech processing technologies are ubiquitous, and speech parameters can be affected by hydration status and lung fluid levels.\u00a0 HearO technology purports to be able to detect changes in speech parameters over time that are related to lung fluid, independent of the language spoken.\u00a0 This technology creates a patient specific speech model while clinically stable and compares the model against daily speech samples; in this manner, patients act as their own controls.\u00a0 While there may be the potential for this approach to predict worsening pulmonary congestion from heart failure (HF), it has yet to be developed and tested in a clinical setting. <\/span><span style=\"font-weight: 400;\">On November 12, 2023 the results of the \u201cSPEECH: Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients\u201d were presented at AHA Scientific Sessions 2023 on behalf of the Cordio HearO Community Study Group.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The purpose of this study was to use the HearO system to analyze ambulatory HF patients\u2019 speech data and to refine and test its ability to detect impending HF worsening. \u00a0 They included outpatient NYHA Class II-III adult heart failure patients regardless of ejection fraction. \u00a0 All patients had baseline creation of their personalized voice model at enrollment.\u00a0 Participants then were instructed to take voice recordings daily at home every morning.\u00a0 HF worsening events were notes, and the voice recordings were analyzed retrospectively.\u00a0 One group was used for development, and the other group was used for testing.\u00a0\u00a0<\/span><span style=\"font-weight: 400;\">There were 362 HF patients in the development group, with 158,024 total recording days and 58 HF events (i.e. worsening requiring hospitalization or outpatient intravenous diuretic therapy). There were 153 HF patients in the test group, with 94,202 recording days and 14 HF worsening events.\u00a0 Patients were in their late 60s, and the majority in both groups spoke Hebrew, with very few speaking English.\u00a0 The mean ejection fraction was ~ 37%.\u00a0 Overall compliance with daily recording was 82.5%.\u00a0 In the test group, the HearO system was able to detect 71% of impending HF worsening events, on average 26 day prior to the event.\u00a0 In the development group, the sensitivity of HearO to detect worsening HF events was superior to daily weight monitoring.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dr. William T. Abraham of Ohio State University concluded: \u201cThe sensitivity detection rate of HearO speech analysis-based telemonitoring was superior to that of daily weight monitoring. Novel speech analysis technology may be useful in remote monitoring of HF patients, providing early warning of worsening HF events including impending decompensation resulting in hospitalization\u2026Ongoing and future studies, including an ongoing US pivotal trial, will continue to define the role of speech measures in the management of heart failure patients.\u201d<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Points Novel speech processing technology has the potential to detect heart failure exacerbations before they happen, and may be better than the conventional weight monitoring approach. Additional studies are needed to explore the generalizability, practicality, efficacy, and effectiveness of the HearO model.<\/p>\n","protected":false},"author":40603,"featured_media":138188,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[883,8],"tags":[885,45,47,185],"ppma_author":[1029],"class_list":{"0":"post-138187","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-aha-2023","8":"category-news","9":"tag-aha-2023","10":"tag-conference","11":"tag-featured","12":"tag-news","13":"author-leah-kosyakovsky"},"authors":[{"term_id":1029,"user_id":40603,"is_guest":0,"slug":"leah-kosyakovsky","display_name":"Leah Kosyakovsky","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/864bde69f6f1f80e91e4a97f0a0ba8daa64c2bb702be09ed787444c7dfa045bb?s=96&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts\/138187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/users\/40603"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=138187"}],"version-history":[{"count":1,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts\/138187\/revisions"}],"predecessor-version":[{"id":138189,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts\/138187\/revisions\/138189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/media\/138188"}],"wp:attachment":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=138187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=138187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=138187"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fppma_author&post=138187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}